Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01933815
Title Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cortice Biosciences, Inc.
Indications

glioblastoma

Therapies

Bevacizumab

TPI 287

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
The Long Island Brain Tumor Center at Neurological Surgery, P.C. Commack New York 11725 United States Details
The Long Island Brain Tumor Center at Neurological Surgery, P.C. Lake Success New York 11042 United States Details
University of Rochester Medical Center Rochester New York 14642 United States Details
The Ohio State University Wexner Medical Center Columbus Ohio 43210 United States Details
Memorial Hermann Hospital Houston Texas 77030 United States Details
Swedish Neuroscience Institute Seattle Washington 98122 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field